Simplex Trading’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2518 |
|
|
2024
Q4 | – | Sell |
-195
| Closed | -$1K | – | 2570 |
|
|
2024
Q3 | $1K | Sell |
195
-1,823
| -90% | -$9.35K | ﹤0.01% | 2063 |
|
|
2024
Q2 | $41K | Buy |
2,018
+1,123
| +125% | +$22.8K | ﹤0.01% | 1422 |
|
|
2024
Q1 | $40K | Buy |
+895
| New | +$40K | ﹤0.01% | 1462 |
|
|
2023
Q4 | – | Sell |
-505
| Closed | -$20K | – | 2534 |
|
|
2023
Q3 | $20K | Buy |
+505
| New | +$20K | ﹤0.01% | 1473 |
|
|
2023
Q2 | – | Sell |
-455
| Closed | -$135K | – | 2514 |
|
|
2023
Q1 | $135K | Buy |
455
+297
| +188% | +$88.1K | ﹤0.01% | 915 |
|
|
2022
Q4 | $54K | Buy |
+158
| New | +$54K | ﹤0.01% | 1252 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2825 |
|
|
2022
Q2 | – | Sell |
-1,100
| Closed | -$367K | – | 2744 |
|
|
2022
Q1 | $367K | Buy |
1,100
+979
| +809% | +$327K | ﹤0.01% | 855 |
|
|
2021
Q4 | $39K | Buy |
121
+52
| +75% | +$16.8K | ﹤0.01% | 1929 |
|
|
2021
Q3 | $31K | Buy |
69
+6
| +10% | +$2.7K | ﹤0.01% | 2141 |
|
|
2021
Q2 | $29K | Sell |
63
-63
| -50% | -$29K | ﹤0.01% | 2197 |
|
|
2021
Q1 | $87K | Sell |
126
-78
| -38% | -$53.9K | ﹤0.01% | 1489 |
|
|
2020
Q4 | $0 | Buy |
+204
| New | – | ﹤0.01% | 2411 |
|
|
2020
Q3 | – | Sell |
-1,961
| Closed | -$1.66M | – | 2204 |
|
|
2020
Q2 | $1.66M | Sell |
1,961
-698
| -26% | -$592K | ﹤0.01% | 190 |
|
|
2020
Q1 | $950K | Buy |
+2,659
| New | +$950K | ﹤0.01% | 310 |
|